Investigators who adjusted clopidogrel dose on the basis of VASP index found they could reduce risk of stent thrombosis as well as MACE at 30 days. Heartwire
The post hoc finding, which was relative to placebo, is unusual for an antiarrhythmic agent. The investigational drug is envisioned as a potentially safer alternative to amiodarone. Heartwire